1 / 6

In-Vitro Diagnostics (IVD) Market To Reach USD 98.3 Billion By 2027

The rising awareness about in vitro diagnostic techniques and continuous research and development in the field of in vitro diagnostic are driving the demand for the market.

ajaychandak01
Télécharger la présentation

In-Vitro Diagnostics (IVD) Market To Reach USD 98.3 Billion By 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In-Vitro Diagnostics (IVD) Market To Reach USD 98.3 Billion By 2027

  2. Market Summary The rising awareness about in vitro diagnostic techniques and continuous research and development in the field of in vitro diagnostic are driving the demand for the market. Market Size – USD 71.8 Billion in 2019, Market Growth - CAGR of 4.6%, Market Trends – Growing health awareness and use of digital health technologies. The Global In Vitro Diagnostics market is forecast to reach USD 98.3 Billion by 2027, according to a new report by Reports and Data. The continuous research and development and the rising awareness about its types are the key driving factors of In Vitro Diagnostics market in the modern health-care world. Though the term “in vitro diagnostics” is not commonly recognized, almost everyone has undergone such testing in their lifetime from an infant to an elderly. The increasing occurrence of accidents and chronic ailments coupled with the growth of the geriatric population are the drivers of the market demand in the forecast period. Growing incidences of surgical procedures are anticipated to fuel the growth of the market. The rising prevalence of target diseases such as diabetes, gastrointestinal diseases, cancer, cardiac disorders, and infectious diseases are contributing to the market growth positively.

  3. Our Approach Our Approach Market Summary The leading players in this market are consistent with product innovations and technology. One of the leading companies in this market, Biomerieux’s R&D draws on more than a century of expertise in infectious disease management and a unique mastery of the three core technologies required for developing in vitro diagnostics. They invest around 12-13% of their sales in R&D, which is the highest percentage of any other IVD company. In Aug 2019, transasia-Erba, part of ERBA Mannheim GmbH Group of Germany, and India's leading in-vitro diagnostic (IVD) products maker increased their R&D budget, doubling its annual R&D spend in a bid to emerge a total solutions provider in the growing field of IVD. Factors impeding the growth of the market are the regulations associated with the use of in-vitro diagnostic test kits. Also, inadequate reimbursement scenarios are expected to act as a restraining factor on the global market in the years ahead. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/943

  4. Our Approach Our Approach Market Summary Key participants Are Roche Diagnostics, Siemens Healthineers, bioMérieux, DiaSorin, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Sysmex Corporation and QIAGEN . For the purpose of this report, Reports and Data have segmented into the global In Vitro Diagnostics market on the basis of product, application, technique, end use, device, and region: Product Outlook (Revenue, USD Billion; 2017-2027) Reagents & Kits Instruments Fully Automated Instruments Semi-Automated Instruments Data Management Software Services Devices Outlook (Revenue, USD Billion; 2017-2027) Reusable IVD Devices Disposable IVD Devices

  5. Our Approach Our Approach Market Summary Application Outlook (Revenue, USD Billion; 2017-2027) Cancer Infectious Diseases Diabetes Gastrointestinal Disease Autoimmune Diseases Cardiac Disease Drug Testing /Pharmacogenomics Hiv/Aids Nephrological Disease Other Order Now: https://www.reportsanddata.com/checkout-form/943

  6. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related